Header Logo

Ondria Gleason

Concepts (116)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Depressive Disorder
4
2013
56
0.770
Why?
Restraint, Physical
1
2022
14
0.730
Why?
Psychiatry
2
2016
27
0.720
Why?
Inpatients
1
2022
60
0.710
Why?
Citalopram
3
2007
7
0.640
Why?
Hepatitis C
4
2008
42
0.630
Why?
Antidepressive Agents, Second-Generation
3
2004
6
0.580
Why?
Antidepressive Agents
4
2018
30
0.570
Why?
Referral and Consultation
2
2008
99
0.480
Why?
Physician Executives
1
2016
5
0.470
Why?
Delirium
3
2006
13
0.450
Why?
Interferon-alpha
3
2007
50
0.430
Why?
Endocrine System Diseases
1
2013
5
0.400
Why?
Hepatitis C, Chronic
2
2007
32
0.380
Why?
Serotonin Uptake Inhibitors
2
2004
26
0.380
Why?
Renal Insufficiency, Chronic
1
2013
47
0.370
Why?
Substance-Related Disorders
2
2013
191
0.310
Why?
Cardiovascular Diseases
1
2013
385
0.290
Why?
Antipsychotic Agents
3
2006
24
0.290
Why?
Mental Disorders
2
2008
118
0.280
Why?
Depressive Disorder, Major
2
2002
127
0.280
Why?
Gastroenterology
1
2008
15
0.270
Why?
Attitude of Health Personnel
1
2008
155
0.250
Why?
Finger Injuries
1
2006
1
0.240
Why?
Self Mutilation
1
2006
1
0.240
Why?
Antiviral Agents
1
2007
114
0.240
Why?
Humans
17
2022
29295
0.230
Why?
Comorbidity
4
2013
262
0.230
Why?
Hallucinations
2
2004
5
0.230
Why?
Spinal Cord Injuries
1
2006
69
0.220
Why?
Depression
1
2007
234
0.210
Why?
Histamine H1 Antagonists
1
2004
1
0.200
Why?
Promethazine
1
2004
1
0.200
Why?
Psychoses, Substance-Induced
1
2004
2
0.200
Why?
Adult
8
2022
8173
0.200
Why?
Indans
1
2003
2
0.200
Why?
Nootropic Agents
1
2003
4
0.200
Why?
Hip Fractures
1
2003
10
0.200
Why?
Cyclohexanols
1
2003
5
0.200
Why?
Epilepsy, Tonic-Clonic
1
2003
5
0.190
Why?
Arthroplasty, Replacement, Hip
1
2003
30
0.190
Why?
Methylphenidate
1
2003
8
0.190
Why?
Male
10
2018
14180
0.190
Why?
Haloperidol
1
2003
8
0.190
Why?
Central Nervous System Stimulants
1
2003
33
0.190
Why?
Hypnotics and Sedatives
1
2003
29
0.190
Why?
Piperidines
1
2003
48
0.190
Why?
Female
11
2018
15883
0.190
Why?
Psychomotor Agitation
1
2022
7
0.190
Why?
Influenza, Human
1
2004
101
0.180
Why?
Clinical Protocols
1
2022
46
0.180
Why?
Patient Safety
1
2022
39
0.180
Why?
Pyridines
1
2003
109
0.180
Why?
Tuberculosis, Central Nervous System
1
2002
1
0.180
Why?
Pirenzepine
1
2002
8
0.180
Why?
Drug Therapy, Combination
4
2018
210
0.170
Why?
Psychotic Disorders
1
2002
23
0.170
Why?
Dose-Response Relationship, Drug
4
2018
614
0.150
Why?
Reproducibility of Results
1
2022
795
0.150
Why?
Postoperative Complications
1
2003
647
0.140
Why?
Severity of Illness Index
3
2007
468
0.140
Why?
Minocycline
1
2018
7
0.140
Why?
Bipolar Disorder
1
2018
42
0.130
Why?
Aspirin
1
2018
125
0.120
Why?
Treatment Outcome
4
2018
2445
0.120
Why?
Aged
4
2013
5656
0.120
Why?
Demography
1
2016
94
0.120
Why?
Academic Medical Centers
1
2016
80
0.110
Why?
Faculty, Medical
1
2016
61
0.110
Why?
Patient Care Team
2
2008
66
0.100
Why?
Gastrointestinal Diseases
1
2013
55
0.100
Why?
Geriatric Assessment
1
2013
91
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2013
68
0.090
Why?
Middle Aged
4
2018
7532
0.080
Why?
Quality of Life
2
2007
523
0.080
Why?
United States
1
2016
2282
0.080
Why?
Hospitals, University
1
2008
28
0.070
Why?
Adolescent
2
2007
3259
0.070
Why?
Health Services Needs and Demand
1
2008
42
0.070
Why?
Data Collection
1
2008
108
0.070
Why?
Ribavirin
1
2007
9
0.060
Why?
Secondary Prevention
1
2007
46
0.060
Why?
Mass Screening
1
2008
160
0.060
Why?
Health Services Accessibility
1
2008
125
0.060
Why?
Quadriplegia
1
2006
5
0.060
Why?
Thiazoles
1
2006
50
0.060
Why?
Piperazines
1
2006
51
0.060
Why?
Pilot Projects
1
2007
467
0.060
Why?
Risk Factors
2
2003
2150
0.060
Why?
Cervical Vertebrae
1
2006
125
0.050
Why?
Follow-Up Studies
1
2007
1034
0.050
Why?
Oklahoma
1
2008
1077
0.050
Why?
Mental Status Schedule
1
2003
9
0.050
Why?
Venlafaxine Hydrochloride
1
2003
1
0.050
Why?
Attention Deficit Disorder with Hyperactivity
1
2003
31
0.050
Why?
Anxiety Disorders
1
2003
67
0.050
Why?
Liver Function Tests
1
2002
9
0.040
Why?
Aspartate Aminotransferases
1
2002
20
0.040
Why?
Alanine Transaminase
1
2002
27
0.040
Why?
gamma-Glutamyltransferase
1
2002
18
0.040
Why?
Treatment Refusal
1
2002
8
0.040
Why?
Benzodiazepines
1
2002
10
0.040
Why?
Length of Stay
1
2003
248
0.040
Why?
Diagnosis, Differential
1
2003
382
0.040
Why?
Epilepsy
1
2002
37
0.040
Why?
Oxandrolone
1
2000
1
0.040
Why?
Anabolic Agents
1
2000
12
0.040
Why?
Injections, Intramuscular
1
1999
22
0.040
Why?
Burns
1
2000
18
0.040
Why?
Drug Administration Schedule
1
1999
225
0.040
Why?
Sick Role
1
1998
9
0.030
Why?
C-Reactive Protein
1
2018
94
0.030
Why?
Psychiatric Status Rating Scales
1
2018
100
0.030
Why?
Logistic Models
1
2018
415
0.030
Why?
Double-Blind Method
1
2018
438
0.030
Why?
Interleukin-6
1
2018
199
0.030
Why?
Gleason's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (116)
Explore
_
Co-Authors (4)
Explore
_
Similar People (56)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_